版本:
中国

Germany's Fresenius weighing bid for generic drugmaker Akorn -Bbg

April 7 German healthcare group Fresenius SE & Co KGaA is weighing a bid for generic drugmaker Akorn Inc, Bloomberg reported on Friday, citing people familiar with the matter.

The companies are in discussions, though no final decisions have been made, Bloomberg reported. bloom.bg/2oN9cMw

Akorn's shares rose as much as 21.5 percent to $30.64 in afternoon trading. The company has a market value of about $3.7 billion.

Fresenius and Akorn were not immediately available for comments. (Reporting by Akankshita Mukhopadhyay in Bengaluru; Editing by Anil D'Silva)

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐